Phoenix Biotechnology, Inc
1 clinical trials · Sponsor
◉ Watch Phoenix Biotechnology, Inc
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety Study of PBI-05204 in Patients With Stage IV Metastatic Pancreatic Adenocarcinoma (NCT02329717) | Phoenix Biotechnology, Inc | 2015-04-01 |
Track Phoenix Biotechnology, Inc automatically
Every clearance here is in the API, with alerts when new ones post.